Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Axitinib SR by Ocular Therapeutix for Non-Proliferative Diabetic Retinopathy (NPDR): Likelihood of Approval
Axitinib SR is under clinical development by Ocular Therapeutix and currently in Phase I for Non-Proliferative Diabetic Retinopathy (NPDR). According...
Axitinib SR by Ocular Therapeutix for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Axitinib SR is under clinical development by Ocular Therapeutix and currently in Phase III for Wet (Neovascular / Exudative) Macular...
Axitinib SR by Alcon for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Axitinib SR is under clinical development by Alcon and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration....